Tamara Kahan
7 Papers
Tamara Kahan is an academic researcher. The author has contributed to research in topics: Interquartile range & Hysterectomy. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
Post-discharge health status and symptoms in patients with severe COVID-19
Himali Weerahandi,Katherine Hochman,Emma Simon,Caroline Blaum,Joshua Chodosh,Emily Duan,Kira Garry,Tamara Kahan,Savannah Karmen-Tuohy,Hannah C. Karpel,Felicia Mendoza,Alexander M Prete,Lindsey Quintana,Jennifer Rutishauser,Leticia Santos Martinez,Kanan Shah,Sneha Sharma,Elias Simon,Ana Z. Stirniman,Leora I. Horwitz +19 more
TL;DR: Patients with severe COVID-19 disease typically experience sequelae affecting their respiratory status, physical health and mental health for at least several weeks after hospital discharge.
Six-Month Outcomes in Patients Hospitalized with Severe COVID-19.
Leora I. Horwitz,Kira Garry,Alexander M Prete,Sneha Sharma,Felicia Mendoza,Tamara Kahan,Hannah C. Karpel,Emily Duan,Katherine Hochman,Himali Weerahandi +9 more
TL;DR: In this article, the authors followed patients discharged after hospitalization for severe COVID-19 to characterize their overall health status and their physical and mental health at 6 months post-hospital discharge.
Trends in concurrent hysterectomy or endometrial sampling at the time of bilateral salpingo-oophorectomy for risk-reducing or therapeutic indications (386)
Simone A Sasse,Sarah Lee,P Rajeev,Sneha Sharma,Tamara Kahan,Bhavana Pothuri +5 more
TL;DR: In this article , the authors analyzed trends and associative factors of risk-reducing or therapeutic BSO with concurrent hysterectomy or endometrial sampling over ten years at a large institution.
Factors associated with concurrent vs. sequentially combined surgery for patients undergoing risk-reducing bilateral salpingo- oophorectomy (434)
TL;DR: In this article , a retrospective cohort study of patients undergoing bilateral salpingo-oophorectomy (BSO) for risk-reducing or therapeutic indications often have additional surgical indications for breast surgery.
Concurrent uterine surgery and uptake of hormone therapy in patients undergoing bilateral salpingo-oophorectomy for risk-reducing or therapeutic indications.
Simone A Sasse,Sarah S. Lee,P Rajeev,Sneha R Sharma,Tamara Kahan,B. Pothuri +5 more
TL;DR: Further research on concurrent uterine surgery is needed to establish standardized treatment recommendations in the risk-reducing and therapeutic BSO population and education regarding the benefits of postoperative HT in eligible patients is warranted.